Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System

Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System is an FDA 510(k)-cleared medical device (K182687) manufactured by Accuray Incorporated. This device is classified under the Radiology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on November 22, 2018. Regulation: 8.